Things are worsening for UnitedHealth Group (NYSE: UNH), with a significant drop in stock value—losing half its worth in 2025—amid poor financial results, a CEO change, and a Department of Justice investigation. Following a disappointing earnings report, the stock’s future remains uncertain, prompting questions about whether it is best to avoid or consider as a contrarian investment.
Want More Context? 🔎
OneSpan (OSPN) Fiscal Q2 EPS Jumps 16%
OneSpan (NASDAQ:OSPN), a provider of digital identity and authentication solutions, reported Q2 fiscal 2025 earnings on August 5, beating Wall Street expectations with non-GAAP EPS of $0.34 and GAAP revenue of $59.8 million, despite a 2% year-over-year decline in total revenue. The company demonstrated improved profitability driven by higher gross margins and a focus on subscription-based revenue, reflecting a shift towards a more sustainable business model. Want More Context? 🔎
Read more